Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease neutropenia
Comorbidity C0024299|lymphoma
Sentences 9
PubMedID- 22536253 In a phase i/ii dose-finding study, activity was observed in heavily pretreated nhl and hodgkin lymphoma (hl) patients, with neutropenia (47%) reported as the most frequent grade 3 or 4 toxicity [52].
PubMedID- 22913768 Economic costs of chemotherapy-induced febrile neutropenia among patients with non-hodgkin's lymphoma in european and australian clinical practice.
PubMedID- 23301757 Randomized comparison of piperacillin-tazobactam plus amikacin versus cefoperazone-sulbactam plus amikacin for management of febrile neutropenia in children with lymphoma and solid tumors.
PubMedID- 24684228 We conducted a cohort study to examine the association between a wide variety of chronic comorbidities and risk of febrile neutropenia (fn) in patients with non-hodgkin lymphoma (nhl) from 2000 to 2009 treated with chemotherapy at kaiser permanente southern california.
PubMedID- 25252614 Background: the primary objective was to describe the total direct inpatient costs among solid tumor and lymphoma patients with chemotherapy-induced febrile neutropenia (fn) and the factors that were associated with higher direct cost.
PubMedID- 22972488 Primary prophylaxis with granulocyte colony-stimulating factor (gcsf) reduces the incidence of febrile neutropenia in patients with non-hodgkin lymphoma (nhl) receiving chop chemotherapy treatment without adversely affecting their quality of life: cost-benefit and quality of life analysis.
PubMedID- 26532567 Cost-effectiveness analysis of granulocyte colony-stimulating factors for the prophylaxis of chemotherapy-induced febrile neutropenia in patients with non-hodgkin's lymphoma in greece.
PubMedID- 21074471 Recent data show that rituximab maintenance therapy significantly increases the risk of both infection and neutropenia in patients with lymphoma or other hematological malignancies.
PubMedID- 21472389 Disseminated cryptococcosis in a non-hodgkin's lymphoma patient with late-onset neutropenia following rituximab-chop chemotherapy: a case report and literature review.

Page: 1